Examkin

Soru

Zorluk: ZorPharmacologic Interventions

A 42-year-old woman is brought to the emergency department by emergency medical services after collapsing and exhibiting generalized tonic-clonic motor activity. Upon arrival, she remains unresponsive with continuous rhythmic jerking of her extremities. Her husband states the seizure began approximately 12 minutes prior to arrival and has not ceased at any point. She has no known medical history and takes no medications. Vital signs show a temperature of 37.8°C (100.0°F), blood pressure of 135/85 mmHg, pulse of 118/min, and respirations of 18/min. Point-of-care blood glucose is 105 mg/dL. Two large-bore intravenous lines are rapidly established.

Arrange the following pharmacologic interventions in the correct protocolized sequence for the escalation of therapy in this patient, from initial first-line stabilization to the management of super-refractory symptoms.

  1. 1Administer an intravenous lorazepam bolus
  2. 2Administer an intravenous fosphenytoin loading dose
  3. 3Initiate a continuous intravenous propofol infusion
  4. 4Initiate a continuous intravenous pentobarbital infusion

Cevap

The correct sequence for managing escalating status epilepticus is: 1) Intravenous lorazepam bolus, 2) Intravenous fosphenytoin loading dose, 3) Continuous intravenous propofol infusion, 4) Continuous intravenous pentobarbital infusion.
The standard protocol for status epilepticus dictates a strict time-based escalation of pharmacologic therapy. Phase 1 (0-10 min) requires a rapid-acting benzodiazepine like IV lorazepam to acutely halt seizure activity. Phase 2 (10-30 min) requires loading a long-acting antiepileptic such as IV fosphenytoin to prevent recurrence. Phase 3 (30-60 min, refractory status epilepticus) requires continuous general anesthetics like IV propofol or midazolam alongside intubation. Finally, Phase 4 (super-refractory, >24 hours) utilizes a deep barbiturate coma with IV pentobarbital, reserved as a last resort due to severe hemodynamic toxicity.

Adım Adım Çözüm

1
Administer a rapid-acting benzodiazepine.
GABAergic inhibition is rapidly enhanced to acutely terminate the ongoing seizure.
Intravenous lorazepam is the drug of choice for early status epilepticus (0-10 minutes) because it penetrates the blood-brain barrier quickly and has a longer duration of seizure suppression in the CNS compared to diazepam.
2
Administer a long-acting, non-benzodiazepine antiepileptic drug.
A sustained seizure threshold is established.
Because the antiepileptic effect of benzodiazepines is transient, an agent like fosphenytoin, levetiracetam, or valproic acid must be loaded during the established status epilepticus phase (10-30 minutes) to prevent recurrence or treat persistent activity.
3
Induce a continuous anesthetic coma.
Cerebral metabolic demand is suppressed, and refractory seizure activity is aborted.
Status epilepticus lasting longer than 30 minutes is considered refractory and carries a high risk of permanent neuronal injury. After securing the airway, continuous infusions of propofol or midazolam are titrated to burst suppression on an electroencephalogram (EEG).
4
Escalate to super-refractory barbiturate therapy.
Profound suppression of all electrographic brain activity is achieved.
If seizures continue or recur after 24 hours of anesthetic infusion, the condition is super-refractory. Pentobarbital is used as a definitive, last-line measure due to its extreme side effect profile, which includes vasoplegia requiring vasopressors.

Anahtar Kavram

The stepwise pharmacologic escalation protocol for status epilepticus (from initial benzodiazepines to super-refractory barbiturate coma).
Bu soruyu puanla

Konular

Pharmacologic Interventions

Bu konudan daha fazla soru